Injectable Fillers Not Recommended as First-Line Option in Nasal Reshaping
An article appearing in a recent issue of Aesthetic Surgery Journal, a publication of the American Society for Aesthetic Plastic Surgery, discusses the benefits and risks of injectable soft tissue fillers as an adjunct to surgical reshaping of the nose.
While rhinoplasty can improve the shape and size of the nose, irregularities and asymmetries following surgery are common. Injecting commercial fillers allows a surgeon to improve on such imperfections without the expense, risk, and recovery required by additional surgery.
Hyaluronic acid, calcium hydroxylapatite gel, and liquid silicone -- all used off-label -- have been employed to treat nasal deformity with varying degrees of success. Silicone, however, is generally not recommended because of a higher risk of nodules, cellulitis, and ulceration.
“The use of any soft tissue filler in the nose should always be approached with caution and with thorough consideration of a patient’s individual circumstances,” says Dr. Steven Dayan of Chicago, one of the article's authors.
As with any medical procedure, proper technique is crucial. Limiting filler use to the top and sides of the nose, avoiding the base and tip, and placing the material at the proper depth in the skin will minimize a bumpy appearance, tissue damage, or interference with proper blood flow in the nose.
“Fillers are no substitute for excellent surgical results,” notes Dr. Dayan. While they may offer effective treatment for certain deformities after surgery, "non-surgical rhinoplasty" with fillers is generally not recommended as a first-line option for nasal reshaping.
Likewise, injectable soft tissue fillers are not recommended for patients seriously considering a corrective operation since any retained material in the nose may complicate future revision surgery.
Full article summary here.
|
